ketendoКлиническая и экспериментальная тиреоидологияClinical and experimental thyroidology1995-54722310-3787Endocrinology Research Centre10.14341/ket2015413-20ketendo-7850Research ArticleНовости мировой тиреоидологииNews of the world thyroidologyНовости мировой тиреоидологии (выпуск 4, 2015)World thyroidology news (#4 2015)МануйловаЮлия АлександровнаManuylovaYuliya Aleksandrovna

канд. мед. наук, ассистент кафедры эндокринологии лечебного факультета

MD, PhD

juliakolish@yahoo.comСвиридоноваМарина АлександровнаSviridonovaMarina Aleksandrovna

канд. мед. наук, научный сотрудник отделения терапии с группой ожирения Института клинической эндокринологии

MD, PhD

juliakolish@yahoo.comШведоваАнна ЕвгеньевнаShvedovaAnna Evgen'evna

врач-эндокринолог

MD

juliakolish@yahoo.comФГБОУ ВПО "Первый Московский Государственный Медицинский Университет им. И.М.Сеченова"РоссияSechenov First Moscow State Medical UniversityRussian FederationФГБУ "Эндокринологический научный центр" Минздрава РоссииРоссияEndocrinology Research CentreRussian FederationООО Медицинская Консультация “Медлайн”РоссияMedical Consultation “Medline”Russian Federation2015180120161141320Copyright © Мануйлова Ю.А., Свиридонова М.А., Шведова А.Е., 20152015Мануйлова Ю.А., Свиридонова М.А., Шведова А.Е.Manuylova Y.A., Sviridonova M.A., Shvedova A.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.cet-endojournals.ru/jour/article/view/7850

Представлены абстракты актуальных международных исследований, посвященных диагностике и лечению различной патологии щитовидной железы, а также влиянию на нее сопутствующих состояний.

The article contains abstracts of actual modern international researches dedicated to management of various thyroid pathology and influence of accompanying states.

гипотиреозамиодарон-индуцированный тиреотоксикозболезнь Грейвсарак щитовидной железыклассификация Бетесдаэндокринная офтальмопатиятиреоидэктомиягипопаратиреозhypothyroidismamiodarone-induced thyrotoxicosisGrave’s diseasethyroid carcinomaBethesda categorizationendocrine orbitopathythyroidectomyhypoparathyroidismReferencesAhn D, Ho Sohn J, Han Jeon J. Hypothyroidism following hemithyroidectomy: incidence, risk factors, and clinical characteristics. J Clin Endocr Metab. 2016:jc.2015-3997. doi: 10.1210/jc.2015-3997.Ahn D, Ho Sohn J, Han Jeon J. Hypothyroidism following hemithyroidectomy: incidence, risk factors, and clinical characteristics. J Clin Endocr Metab. 2016:jc.2015-3997. doi: 10.1210/jc.2015-3997.Arpaci D, Gurkan Tocoglu A, Yilmaz S, et al. Epicardial Adipose Tissue Thickness in Patients With Subclinical Hypothyroidism and the Relationship Thereof With Visceral Adipose Tissue Thickness. J Clin Med Res. 2016;8(3):215-219. doi: 10.14740/jocmr2460w.Arpaci D, Gurkan Tocoglu A, Yilmaz S, et al. Epicardial Adipose Tissue Thickness in Patients With Subclinical Hypothyroidism and the Relationship Thereof With Visceral Adipose Tissue Thickness. J Clin Med Res. 2016;8(3):215-219. doi: 10.14740/jocmr2460w.Maqdasy S, Batisse-Lignier M, Auclair C, et al. Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction. The American Journal of Cardiology. 2016;117(7):1112-1116. doi: 10.1016/j.amjcard.2016.01.003.Maqdasy S, Batisse-Lignier M, Auclair C, et al. Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction. The American Journal of Cardiology. 2016;117(7):1112-1116. doi: 10.1016/j.amjcard.2016.01.003.Villagelin D, Romaldini JH, Santos RB, et al. Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment. Thyroid. 2015;25(12):1282-1290. doi: 10.1089/thy.2015.0195.Villagelin D, Romaldini JH, Santos RB, et al. Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment. Thyroid. 2015;25(12):1282-1290. doi: 10.1089/thy.2015.0195.Patel D, Kitahara CM, Park Y, et al. Thyroid Cancer and Nonsteroidal Anti-Inflammatory Drug Use: A Pooled Analysis of Patients Older Than 40 Years of Age. Thyroid. 2015;25(12):1355-1362. doi: 10.1089/thy.2015.0198.Patel D, Kitahara CM, Park Y, et al. Thyroid Cancer and Nonsteroidal Anti-Inflammatory Drug Use: A Pooled Analysis of Patients Older Than 40 Years of Age. Thyroid. 2015;25(12):1355-1362. doi: 10.1089/thy.2015.0198.Pakkila F, Mannisto T, Hartikainen AL, et al. Maternal and Child's Thyroid Function and Child's Intellect and Scholastic Performance. Thyroid. 2015;25(12):1363-1374. doi: 10.1089/thy.2015.0197.Pakkila F, Mannisto T, Hartikainen AL, et al. Maternal and Child's Thyroid Function and Child's Intellect and Scholastic Performance. Thyroid. 2015;25(12):1363-1374. doi: 10.1089/thy.2015.0197.Ito Y, Miyauchi A, Kudo T, et al. Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital. Thyroid. 2016;26(1):156-160. doi: 10.1089/thy.2015.0393.Ito Y, Miyauchi A, Kudo T, et al. Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital. Thyroid. 2016;26(1):156-160. doi: 10.1089/thy.2015.0393.Liu X, Medici M, Kwong N, et al. Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis. Thyroid. 2016;26(2):256-261. doi: 10.1089/thy.2015.0376.Liu X, Medici M, Kwong N, et al. Bethesda Categorization of Thyroid Nodule Cytology and Prediction of Thyroid Cancer Type and Prognosis. Thyroid. 2016;26(2):256-261. doi: 10.1089/thy.2015.0376.Jespersen S, Nygaard B, Kristensen LO. Methylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency. Eur Thyroid J. 2015;4(4):222-225. doi: 10.1159/000440834.Jespersen S, Nygaard B, Kristensen LO. Methylprednisolone Pulse Treatment of Graves' Ophthalmopathy Is Not Associated with Secondary Adrenocortical Insufficiency. Eur Thyroid J. 2015;4(4):222-225. doi: 10.1159/000440834.Suwannasarn M, Jongjaroenprasert W, Chayangsu P, et al. Single measurement of intact parathyroid hormone after thyroidectomy can predict transient and permanent hypoparathyroidism: a prospective study. Asian J Surg. 2016. doi: 10.1016/j.asjsur.2015.11.005.Suwannasarn M, Jongjaroenprasert W, Chayangsu P, et al. Single measurement of intact parathyroid hormone after thyroidectomy can predict transient and permanent hypoparathyroidism: a prospective study. Asian J Surg. 2016. doi: 10.1016/j.asjsur.2015.11.005.Staniforth JU, Erdirimanne S, Eslick GD. Thyroid carcinoma in Graves' disease: A meta-analysis. Int J Surg. 2016;27:118-125. doi: 10.1016/j.ijsu.2015.11.027.Staniforth JU, Erdirimanne S, Eslick GD. Thyroid carcinoma in Graves' disease: A meta-analysis. Int J Surg. 2016;27:118-125. doi: 10.1016/j.ijsu.2015.11.027.Boj-Carceller D, Sanz-Paris A, Sanchez-Oriz E, et al. Treatment of Subclinical Hyperthyroidism: Effect on Body Composition. Nutr Hosp. 2015;32(5):2331-2337. doi: 10.3305/nh.2015.32.5.9660.Boj-Carceller D, Sanz-Paris A, Sanchez-Oriz E, et al. Treatment of Subclinical Hyperthyroidism: Effect on Body Composition. Nutr Hosp. 2015;32(5):2331-2337. doi: 10.3305/nh.2015.32.5.9660.Lee YY, Tam KW, Lin YM, et al. Recombinant human thyrotropin before (131)I therapy in patients with nodular goitre: a meta-analysis of randomized controlled trials. Clin Endocrinol (Oxf). 2015;83(5):702-710. doi: 10.1111/cen.12654.Lee YY, Tam KW, Lin YM, et al. Recombinant human thyrotropin before (131)I therapy in patients with nodular goitre: a meta-analysis of randomized controlled trials. Clin Endocrinol (Oxf). 2015;83(5):702-710. doi: 10.1111/cen.12654.Gabalec F, Srbova L, Nova M, et al. Impact of Hashimoto's thyroiditis, TSH levels, and anti-thyroid antibody positivity on differentiated thyroid carcinoma incidence. Endokrynol Pol. 2016;67(1):48-53. doi: 10.5603/EP.a2016.0022.Gabalec F, Srbova L, Nova M, et al. Impact of Hashimoto's thyroiditis, TSH levels, and anti-thyroid antibody positivity on differentiated thyroid carcinoma incidence. Endokrynol Pol. 2016;67(1):48-53. doi: 10.5603/EP.a2016.0022.Perros P, Zarkovic M, Azzolini C, et al. PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012. Br J Ophthalmol. 2015;99(11):1531-1535. doi: 10.1136/bjophthalmol-2015-306733.Perros P, Zarkovic M, Azzolini C, et al. PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012. Br J Ophthalmol. 2015;99(11):1531-1535. doi: 10.1136/bjophthalmol-2015-306733.

The authors declare that there are no conflicts of interest present.